Celltrion
Celltrion's Overview
Celltrion Inc. is a leading South Korean biopharmaceutical company headquartered in Incheon. Specializing in the research, development, manufacturing, and commercialization of biosimilar drugs and innovative therapies, Celltrion aims to enhance healthcare accessibility and outcomes globally. The company has a strong pipeline in autoimmune diseases, oncology, and other critical therapeutic areas, leveraging advanced biotechnology to produce high-quality, affordable medicines. Following its recent merger with Celltrion Healthcare (completed in December 2023), the integrated entity is poised for accelerated growth and expanded global market penetration, committed to addressing unmet medical needs and contributing to human health.
Where is Celltrion's Headquarters?
HQ Function
Serves as the central hub for corporate management, research and development (R&D), and advanced biopharmaceutical manufacturing.
Notable Features:
State-of-the-art R&D laboratories, large-scale cGMP-compliant manufacturing facilities (Plant 1, Plant 2, and an upcoming Plant 3), and modern office complexes. Located in the Songdo International Business District, a smart city and biotech hub.
Work Culture:
A dynamic and innovative environment focused on scientific excellence, collaboration, and rapid execution. Emphasizes a strong 'can-do' spirit and dedication to improving global health through biopharmaceutical advancements.
HQ Significance:
The Incheon headquarters is critical to Celltrion's identity as a global biopharma leader, housing its core innovation engine, manufacturing capabilities, and strategic operations that support its worldwide activities.
Values Reflected in HQ: The headquarters reflects Celltrion's core values of innovation, quality, and global ambition through its advanced technological infrastructure, strategic location in a high-tech hub, and continuous investment in R&D and manufacturing excellence.
Location:
Celltrion maintains a robust global presence, supporting a wide range of functions including cutting-edge research and development, large-scale biopharmaceutical manufacturing, extensive clinical trials, complex regulatory affairs, and comprehensive commercial operations. Its products are marketed and distributed in over 110 countries worldwide through a network of local subsidiaries, strategic partnerships, and commercial agreements. This global reach ensures broad patient access to its portfolio of biosimilars and innovative drugs across key regions such as North America, Europe, Asia, Latin America, and the Middle East.
Street Address:
23, Academy-ro, Yeonsu-gu
City:
Incheon
State/Province:
Incheon
Country:
South Korea
Celltrion's Global Presence
Jersey City, NJ, USA
Address: 200 Hudson St Ste 602, Jersey City, NJ 07302, USA
To expand Celltrion's footprint in the North American market, engage with regulatory bodies like the FDA, build relationships with healthcare providers, and support patient access to its advanced therapies.
Budapest, Hungary
Address: 1133 Budapest, Váci út 76. Capital Square I. ép. IV. em, Hungary
To strengthen Celltrion's presence across Europe, navigate the diverse regulatory and market access landscapes of various European countries, and ensure the timely and efficient supply of medicines to European patients.
Buying Intent Signals for Celltrion
Highperformr Signals uncover buying intent and give you clear insights to target the right accounts at the right time — helping your sales, marketing, and GTM teams close more deals, faster.
Executive Team of Celltrion
As of April 2025, Celltrion' leadership includes:
Investors of Celltrion
Celltrion has been backed by several prominent investors over the years, including:
Executive New Hires/Exits in the Last 12 Months
The past 12 months at Celltrion have been defined by significant strategic consolidation, primarily the merger between Celltrion and Celltrion Healthcare, finalized in December 2023. This pivotal event has led to a restructuring of the executive leadership to effectively guide the integrated company. Chairman Seo Jung-jin has been central in spearheading these transformative efforts. Key executives from both merged entities have transitioned into new strategic roles within the unified structure of Celltrion Inc.
Departures
New Appointments:
Technology (Tech Stack) used by Celltrion
Discover the tools Celltrion uses. Highperformr reveals the technologies powering your target accounts — helping your sales, marketing, and GTM teams prioritize smarter and close faster.
Celltrion Email Formats and Examples
Celltrion typically utilizes standardized email formats for its employees, generally combining elements of an employee's name with the company domain '@celltrion.com'. Common patterns include the first initial followed by the last name, or the full first name separated from the last name by a period. Recognizing these formats can aid in professional outreach.
[first_initial][last_name]@celltrion.com OR [first_name].[last_name]@celltrion.com
Format
jsmith@celltrion.com
Example
75%
Success rate
News and media
Celltrion IR • May 9, 2024
Celltrion Reports Strong Q1 2024 Results Post-Merger, Driven by Key Product Growth
Celltrion announced its Q1 2024 consolidated revenues of KRW 737 billion, a 23.1% increase year-over-year, marking its first quarterly report post-merger with Celltrion Healthcare. The growth was driven by strong sales of Yuflyma and the U.S. launch of Zymfentra. Operating profit was KRW 15.4 billion, impacted by one-off merger-related costs and Zymfentra launch expenses....more
Business Wire • March 18, 2024
Celltrion USA Launches ZYMFENTRA™ (infliximab-dyyb), World’s First Subcutaneous Infliximab, in the U.S.
Celltrion USA announced the U.S. launch of ZYMFENTRA™ (infliximab-dyyb), the first and only subcutaneous formulation of infliximab approved by the FDA. This innovative product offers a new, convenient treatment option for patients with inflammatory bowel diseases (IBD), such as Crohn's disease and ulcerative colitis....more
Highperformr’s free tools for company research
Explore Employees by Region or Country
See where a company’s workforce is located, by country or region.
View Funding Details
View past and recent funding rounds with amounts and investors.
Understand Revenue Insights
Understand company revenue estimates and financial scale.
Track Active Job Openings
Track active roles and hiring trends to spot growth signals.
Review Product and Offerings
Discover what a company offers—products, platforms, and solutions.
Get SIC or NAICS Codes
Get the company’s official SIC and NAICS classifications.
Analyze Website Traffic Trends
Analyze visitor volume, engagement, and top traffic sources.
Discover Social Profiles and Engagement
Explore LinkedIn, Twitter, and other active social profiles.
Identify Top Competitors
Identify top competitors based on similar business traits.
Research and Discover Companies with Highperformr — Smarter, Faster
Explore companies in depth — from the tech they use to recent funding, hiring trends, and buyer signals — all in one powerful view.
Highperformr AI helps you surface the right accounts and enrich your CRM with verified company and contact insights, so your teams can prioritize and engage faster.
- Track intent signals to find buyers who are actively in-market
- Enrich contacts and companies instantly, no need to switch tools
- Automate workflows to stay ahead of every change
- Connect your CRM & tools for seamless data sync and activation
Thousands of companies, including Celltrion, are just a search away.